How to deal with the situation when osimertinib is ineffective
Osimertinib, as a targeted drug targeting EGFR mutations, plays an important role in the treatment of non-small cell lung cancer (NSCLC). However, some patients may experience ineffectiveness after taking osimertinib.
The specific reasons why osimertinib is ineffective need to be confirmed. Re-perform genetic testing to confirm whether there is an EGFR mutation or other related gene mutations. The efficacy of osimertinib mainly depends on the presence of EGFR mutations. If the patient does not have this mutation or has other types of mutations, osimertinib may not be able to work. Analyze whether drug resistance has emerged. Resistance may be caused by new mutations in tumor cells that may render osimertinib ineffective in inhibiting tumor growth.

Based on the analysis results of the cause of inefficiency, if other gene mutations are found, such as MET amplification or overexpression, other targeted drugs can be considered, such as MET inhibitors, or a treatment strategy of osimertinib combined with other targeted drugs. If no EGFR mutations or other targetable gene mutations are detected, or if drug resistance is a serious problem, chemotherapy or immunotherapy can be considered. Chemotherapy uses drugs to kill or inhibit the growth of cancer cells, while immunotherapy activates the patient's own immune system to attack cancer cells.
For patients who fail to respond to standard treatments, they may also consider participating in clinical trials to try new treatments. Currently, new treatments for non-small cell lung cancer are emerging, including new targeted drugs, immunotherapy, and cell therapy.
In addition to adjustments to medical treatments, patients also need psychological and lifestyle support. Faced with ineffective treatment, patients may experience anxiety and fear. At this time, psychological counseling and family support are crucial. At the same time, maintaining a healthy lifestyle, including a reasonable diet, moderate exercise, and adequate rest, can also help improve the patient's overall health and ability to cope with treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)